Path: news-archive.icm.edu.pl!news2.icm.edu.pl!newsfeed.silweb.pl!news.us.edu.pl!news
.nask.pl!news.nask.org.pl!news.germany.com!postnews.google.com!o80g2000hse.goog
legroups.com!not-for-mail
From: darked <d...@g...com>
Newsgroups: pl.sci.medycyna
Subject: Re: Pytanie o chelatoterapie!!!
Date: Tue, 02 Oct 2007 10:50:31 -0000
Organization: http://groups.google.com
Lines: 35
Message-ID: <1...@o...googlegroups.com>
References: <fdrkol$puu$1@atlantis.news.tpi.pl>
NNTP-Posting-Host: 155.198.233.119
Mime-Version: 1.0
Content-Type: text/plain; charset="iso-8859-2"
Content-Transfer-Encoding: quoted-printable
X-Trace: posting.google.com 1191322232 27575 127.0.0.1 (2 Oct 2007 10:50:32 GMT)
X-Complaints-To: g...@g...com
NNTP-Posting-Date: Tue, 2 Oct 2007 10:50:32 +0000 (UTC)
In-Reply-To: <fdrkol$puu$1@atlantis.news.tpi.pl>
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (X11; U; Linux i686; en-US; rv:1.8.1.6) Gecko/20061201
Firefox/2.0.0.6 (Ubuntu-feisty),gzip(gfe),gzip(gfe)
Complaints-To: g...@g...com
Injection-Info: o80g2000hse.googlegroups.com; posting-host=155.198.233.119;
posting-account=ps2QrAMAAAA6_jCuRt2JEIpn5Otqf_w0
Xref: news-archive.icm.edu.pl pl.sci.medycyna:237962
Ukryj nagłówki
On Oct 1, 9:18 pm, "AdamC" <c...@p...onet.pl> wrote:
> Czy ktoś może wie o ośrodku w Polsce w którym stosują chelatoterapie
> (rozpuszczanie złogów cholesterolu w tętnicach), gdzie taki ośrodek się
> znajduje, w jakim mieście (oprócz woj. zachodnio-pomorskiego) bo wiem że tam
> są dwa takie ośrodki. ???
Bzdura totalna:
Za: http://www.quackwatch.com/01QuackeryRelatedTopics/ch
elation.html
"""results of two randomized, controlled, double-blind clinical trials
of chelation therapy were published in peer-reviewed German medical
journals. The first was conducted by Curt Diehm, M.D., at the
University of Heidelberg Medical Clinic [3]. Diehm studied 45 patients
who had intermittent claudication, a condition in which impaired
circulation causes the individual to develop pain in the legs upon
walking. About half of the patients were treated with EDTA and the
rest received Bencyclan, a bloodthinning agent. In addition to
determining the effect of each agent on the ability to perform pain-
free walking exercises, Diehm measured the progress of the disease
process in each patient during the four-week treatment period and
three months after treatment was stopped. Statistical evaluation of
the results after the blinding code was broken showed that patients in
both groups had equally increased ability to perform pain-free walking
exercises and that treatment with EDTA did not result in any change in
the patients' blood flow, red cell viscosity, red-cell aggregation, or
triglyceride and cholesterol levels. Diehm also concluded that the
improvements in walking measurements in both groups were directly
related to his success in convincing them of his strong interest in
their well being and his ability to motivate them to make an effort to
perform greater activity."""
|